Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Gdowski

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|August 13, 2017
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trialsAndrew S Gdowski, Amalendu Ranjan, Jamboor K Vishwanatha
Nanomedicine (London, England)|August 15, 2017
Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and painAndrew S Gdowski, Amalendu Ranjan, Marjana R Sarker, et al.
ACS Applied Nano Materials|February 15, 2021
Bioinspired Nanoparticles Engineered for Enhanced Delivery to the BoneAndrew S Gdowski, Jana B Lampe, Victor J T Lin, et al.
The Journal of Clinical Investigation|January 16, 2024
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppressionAtsushi Okato, Takanobu Utsumi, Michela Ranieri, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Experimental & Clinical Cancer Research : CR|August 13, 2017
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trialsAndrew S Gdowski, Amalendu Ranjan, Jamboor K Vishwanatha
Nanomedicine (London, England)|August 15, 2017
Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and painAndrew S Gdowski, Amalendu Ranjan, Marjana R Sarker, et al.
ACS Applied Nano Materials|February 15, 2021
Bioinspired Nanoparticles Engineered for Enhanced Delivery to the BoneAndrew S Gdowski, Jana B Lampe, Victor J T Lin, et al.
The Journal of Clinical Investigation|January 16, 2024
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppressionAtsushi Okato, Takanobu Utsumi, Michela Ranieri, et al.
Pageof 1